Company Filing History:
Years Active: 2014
Title: Gema Panizo: Innovator in Oligonucleotide-Based Therapies
Introduction
Gema Panizo is a notable inventor based in Madrid, Spain. She has made significant contributions to the field of oligonucleotide-based therapies. Her innovative work focuses on the development of novel oligomer analogues that have the potential to revolutionize gene expression inhibition.
Latest Patents
Gema Panizo holds a patent for "Sphingosine-bound siRNA." This invention relates to novel oligomer analogues and their application in oligonucleotide-based therapies. More specifically, it concerns oligonucleotides that carry lipid molecules, which can serve as potential inhibitors of gene expression. This patent highlights her expertise and commitment to advancing therapeutic technologies.
Career Highlights
Gema Panizo is currently associated with Sylentis S.A.U., where she continues to push the boundaries of research in her field. Her work has garnered attention for its innovative approach to addressing complex biological challenges.
Collaborations
Gema collaborates with talented individuals such as Ana Isabel Jimenez and Tamara Martinez. These partnerships enhance her research and contribute to the development of groundbreaking therapies.
Conclusion
Gema Panizo is a pioneering inventor whose work in oligonucleotide-based therapies is paving the way for new medical advancements. Her contributions are vital to the ongoing evolution of gene expression inhibition technologies.